<DOC>
	<DOCNO>NCT02320643</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , recurrence , postoperative complication partially absorbable mesh ( Seratom®PA ) patient pelvic organ prolapse .</brief_summary>
	<brief_title>A Pilot Study Investigate Efficacy Partially Absorbable Mesh Patients With Pelvic Organ Prolapsed</brief_title>
	<detailed_description>Patients pelvic organ prolapse administrate partially absorbable mesh ( Seratom®PA ) . It perform pelvic organ prolapse quantification ( POP-Q ) examination , quality life ( QOL ) questionnaire complication postop 2week , 12week , 24week .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>1 . Woman age 41 year old 2 . Subjects symptomatic pelvic organ prolapse quantification ( POPQ ) stage II &amp; cystocele high require surgical repair 3 . Subjects desire vaginal reconstructive surgery 4 . Subjects uterus &lt; 12 week size 5 . Subjects able complete study questionnaire assessment 6 . Subjects available 6 month followup 1 . Subjects medical contraction , e.g . current urinary tract , vaginal pelvic infection , history pelvic irradiation , history lower urinary tract malignancy , chronic steroid use , compromise immune system 2 . Subjects receive anticoagulation therapy 3 . Subjects current intermittent catheterization 4 . Subjects whose BMI 30kg/m2 5 . Subjects uncontrolled diabetes 6 . Subjects medication could result compromise immune response , immune modulators 7 . Subjects currently pregnant intend become pregnant study period &lt; 12 month postpartum 8 . Subjects receive laparoscopic abdominal pelvic surgery past 1 month 9 . Subjects need concomitant surgery require abdominal incision 10 . Subjects prior prolapse implant procedure ( i.e . IVS tunneler , Perigee , Apogee , graft augment repair , etc ) Note : previous traditional repair allow . 11 . Subjects radiation therapy pelvic area 12 . Subjects pelvic cancer pelvic cancer within past 12 month cytostatic medication within past 12 month 13 . Subjects shorten vagina know Mullerian anomaly ( e.g . uterine didelphys . ) 14 . Subjects know neurologic medical condition affect bladder function ( e.g . Multiple Sclerosis , spinal cord injury ) 15 . Subjects know hypersensitivity graft material ( )</criteria>
	<gender>Female</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Partially absorbable mesh</keyword>
</DOC>